NEW YORK – Clever Leaves (the “Company”), a number one multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical hashish and hemp extracts, has been granted European Union Good Manufacturing Practices (EU GMP) certification by the Croatian Agency for Medicinal Products and Medical Devices (HALMED) for its pharmaceutical post-harvest facility and laboratory situated outdoors Bogota, Colombia, to provide Active Pharmaceutical Ingredients (API), semi-finished and completed hashish merchandise for medical functions.

The certification acknowledges that Clever Leaves’ manufacturing amenities adjust to high quality requirements and manufacturing pointers required by the EU for the manufacturing of hashish and hemp-based pharmaceutical merchandise. EU GMP certification is usually required to import medical hashish merchandise into the European Union and is anticipated to broaden Clever Leaves’ means to serve worldwide markets.


“EU GMP certification greatly expands Clever Leaves’ ability to serve the burgeoning European medical cannabis and hemp markets, which have very strict quality, compliance and regulatory requirements. EU GMP certification expands an early mover advantage for Clever Leaves in the pharmaceutical channel as global demand increases and more legal cannabis geographies emerge,” mentioned Kyle Detwiler, CEO of Clever Leaves.

“As the first company in Latin America and one of a few medical cannabis companies in the world with EU GMP certification, this is a major accomplishment for our operations, regulatory, and quality control teams, and speaks to our commitment to provide our clients and patients with high quality and consistent, pharmaceutical grade products,” mentioned Andres Fajardo, President of Clever Leaves.

Clever Leaves is a world chief in low-cost, prime quality and large-scale cannabinoid manufacturing. The Company is without doubt one of the world’s largest medical hashish operations when it comes to capability, boasting 1.eight million sq. ft of present cultivation capability in Colombia and 108,000 kg/yr of extraction capability in addition to a pre-licensed cultivation operation in Portugal. Clever Leaves can be happy to announce that up to now the Company has exported merchandise to Australia, Brazil, Canada, Germany, Great Britain, Poland and the United States, amongst others.

Clever Leaves has achieved a number of vital milestones together with turning into the primary and solely Colombian hashish firm to be GMP licensed by INVIMA, the Colombian meals and drug company, in addition to the primary to obtain Good Agricultural and Collecting Practices (GACP) certification within the Americas by the Control Union´s Medical Cannabis Standard (CUMCS).

About Clever Leaves
Clever Leaves is a multi-national hashish firm with a mission to function in compliance with federal and state legal guidelines and with an emphasis on ecologically sustainable, large-scale cultivation and processing because the cornerstones of its international hashish enterprise. Clever Leaves is a number one vertically built-in producer of medical hashish and hemp extracts and is at the moment cultivating over 1.eight million sq. ft of greenhouses beneath Good Agricultural and Collection Practices (GACP) in Colombia. Clever Leaves’ Colombian operation maintains European Union Good Manufacturing Practices (EU GMP) certification in addition to Good Manufacturing Practices certification from INVIMA, Colombia’s meals and drug regulatory company. Clever Leaves’ first extraction facility is at the moment able to extracting greater than 100.000 kilograms of dried flower per yr. In November 2019, Clever Leaves obtained a pre-license discover and authorization from INFARMED I.P., the Portuguese pharmaceutical regulatory authority, to begin preliminary cultivation operations for R&D functions in Portugal. Based on this authorization, Clever Leaves Portugal was in a position to domesticate medicinal hashish for analysis and improvement functions on its 85-hectare farm. Clever Leaves is without doubt one of the world’s largest hemp and medical hashish producers, with a world footprint encompassing manufacturers, extraction amenities, cultivation operations and different investments throughout Canada, Colombia, Germany, Portugal, and the United States.

Source link